T1	Participants 606 710	Pregnant women with WHO stage 1, 2, or 3 HIV-1 infection who had CD4 cell counts of 200-500 cells per Î¼L
T2	Participants 1446 1453	infants
T3	Participants 2032 2056	882 women were enrolled,
